BridgeMD
New treatment option for Delirium
Official title Simultaneous Recumbent Cycling and Cognitive Training
ClinicalTrials.gov ID: NCT04556227
What this study is testing
- What it's testing
- Intensive care units (ICU) provide life-saving care for nearly five million people annually. Up to 80% of patients receiving care in an ICU experience at least one episode of delirium.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 64
You may be able to join if
- Age 45-64 years
- Admitted to medical or surgical ICUs (SLH \& TMC) for \>24 hours
- English-speaking
- Discharged home
- Able to provide consent
You likely can't join if
- Cancer diagnosis with short life expectancy determined by the Primary Care Provider (unable to complete the study within time frame)
- Chemotherapy (drug-induced impaired cognition)
- Diagnosed vascular dementia or other neurodegenerative diseases (e.g. Alzheimer or Parkinson disease)
- Documented alcohol consumption ≥5 drinks/day (withdrawal delirium tremens)
- Corrected vision\<20/80 Snellen chart (unable to do cognitive exercises on the tablet)
- Examiner rated low hearing or communicative ability that would interfere with intervention and assessments
See the full eligibility criteria
- Age 45-64 years
- Admitted to medical or surgical ICUs (SLH \& TMC) for \>24 hours
- English-speaking
- Discharged home
- Able to provide consent
- Access to a telephone
- One or more delirium episode in ICU (positive CAM-ICU).
- Cancer diagnosis with short life expectancy determined by the Primary Care Provider (unable to complete the study within time frame)
- Chemotherapy (drug-induced impaired cognition)
- Diagnosed vascular dementia or other neurodegenerative diseases (e.g. Alzheimer or Parkinson disease)
- Documented alcohol consumption ≥5 drinks/day (withdrawal delirium tremens)
- Corrected vision\<20/80 Snellen chart (unable to do cognitive exercises on the tablet)
- Examiner rated low hearing or communicative ability that would interfere with intervention and assessments
- Positive CAM-ICU (delirium) at hospital discharge
- Unable to participate in rehabilitation (abnormal 6 min walk test)
- Any physical condition preventing recumbent cycling
- Recent documented history of drug abuse.
The study team makes the final eligibility decision.
Where it's taking place
- Kansas City, Missouri, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kansas City, Missouri, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.